Fisher & Paykel – Buy
Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now within our highlighted range.
Watch the short-term momentum indicators for a turn higher.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now within our highlighted range.
Watch the short-term momentum indicators for a turn higher.

Sonic Healthcare is under Algo Engine buy conditions and is a current holding in our ASX 100 model.

Woodside Petroleum is under Algo Engine buy conditions and is a current holding in our ASX 100 model.

CSL:ASX 1H21 NPAT of US$1.8bn. FY21 guidance retained at US$2.2bn, which implies a weaker 2H21.
We expect to see earnings upgraded prior to the completion of the 2H.
CSL trades on a forward yield of 1%.

Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Northern Star Resources is under Algo Engine buy conditions.
Super Pit joint owners Northern Star and Saracen Mineral Holdings have now completed the merger. We see upside for the stock price from these levels and NST is now added to our “high conviction” list.

Goodman is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
Relative to its A-REIT peers, GMG is trading on an elevated earnings multiple, however, this is not the case when compared to its global peers.
We expect 10% EPS growth into FY22 and the 2% plus dividend yield remains well supported.

Cleanaway Waste Management is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
1H21 EBITDA was up 3% on the same time last year. Full-year EBITDA growth should remain within the 3 to 5% growth range and
overall FY21 EBITDA of $525m to $540m is expected.
CWY trades on a forward yield of 2%.
ORA:ASX has rallied 15% since switching to Algo Engine buy conditions in mid-January.
The company reported 1H21 sales of $1.81 billion, down 1% and EBIT of $140 million up 5%.
The share buyback will continue to underpin the share price, along with the attractive 4.5% yield.

Or start a free thirty day trial for our full service, which includes our ASX Research.